{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:27:14Z","timestamp":1782818834692,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Waiver discount request","award":["Ticket ID #85288"],"award-info":[{"award-number":["Ticket ID #85288"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Human Immunodeficiency Virus (HIV) infection causes a myriad of neurological complications including cognitive deficits referred to as HIV-Associated Neurocognitive Disorders (HAND). With the introduction of combination antiretroviral therapy, there has been an epidemiological shift in cognitive disorders with a decline in the more severe HIV-Associated Dementia (HAD) to an increase in the less severe HAND: Asymptomatic Neurocognitive Impairment (ANI) and HIV-associated Mild Neurocognitive Disorder (MND). Central Nervous System (CNS) involvement in HIV interferes with cognitively demanding activities of daily living and hence a worse quality of life. Early diagnosis is delayed until symptoms are overt.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a cross sectional analytical study of HIV infected persons on antiretroviral therapy attending HIV clinic. A systematic random sampling was done to select 360 patients. An interviewer administered structured questionnaire was used to collect socio-demographic data while the CD4 count and viral load were retrieved from the Academic Model Providing Access to Healthcare (AMPATH) database. Pearson\u2019s Chi Square test was used to compare proportions while independent sample t- test was used to compare continuous variables between the patients diagnosed with HAND and those without HAND. Logistic regression model was used to assess the factors associated with HAND.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The mean age of the study participants was 40.2\u2009years. The overall prevalence of HAND was (81.1%) <jats:italic>N<\/jats:italic>\u2009=\u2009292. Mild HAND (ANI and MND) was present (78.6%) <jats:italic>N<\/jats:italic>\u2009=\u2009283, Severe HAND (HAD) (2.5%) <jats:italic>N<\/jats:italic>\u2009=\u20099. The factors associated with HAND were older age OR: 1.06 (95% CI: 1.03, 1.10), male gender OR: 0.48 (95% CI: 0.24, 0.97), Advanced WHO clinical staging OR: 2.45 (95% CI: 1.20, 5.01) and a higher level of education; secondary\/tertiary OR: 0.16 (95% CI: 0.07, 0.38); 0.11 (95% CI: 0.04, 0.35).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The prevalence of HAND in this study population was found to be high (81.1%). Older age and advanced WHO clinical staging were associated with an increased risk of hand while higher level of education and male gender were protective.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01857-3","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T08:02:45Z","timestamp":1594713765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-7639","authenticated-orcid":false,"given":"Amina Ali","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrispine","family":"Oduor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kinyanjui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"1857_CR1","volume-title":"AIDS and neurology","author":"MJG Harrison","year":"1995","unstructured":"Harrison MJG, M. J. AIDS and neurology. Edinburgh: Churchill Livingstone; 1995."},{"issue":"11","key":"1857_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","volume":"13","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013;13(11):976\u201386.","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"1857_CR3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789\u201399.","journal-title":"Neurology"},{"issue":"9","key":"1857_CR4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","volume":"24","author":"S Simioni","year":"2010","unstructured":"Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS (London, England). 2010;24(9):1243\u201350.","journal-title":"AIDS (London, England)"},{"issue":"9","key":"1857_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1097\/QAD.0b013e3283391d56","volume":"24","author":"JC McArthur","year":"2010","unstructured":"McArthur JC, Brew BJ. HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS (London, England). 2010;24(9):1367\u201370.","journal-title":"AIDS (London, England)"},{"issue":"Pt 1","key":"1857_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.2044-8295.1997.tb02625.x","volume":"88","author":"HD Ellis","year":"1997","unstructured":"Ellis HD, Jones DM, Mosdell N. Intra- and inter-modal repetition priming of familiar faces and voices. Br J Psychol (London, England: 1953). 1997;88(Pt 1):143\u201356.","journal-title":"Br J Psychol (London, England: 1953)"},{"issue":"5","key":"1857_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/ana.410340527","volume":"34","author":"R Mayeux","year":"1993","unstructured":"Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tycko B, Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol. 1993;34(5):752\u20134.","journal-title":"Ann Neurol"},{"issue":"3","key":"1857_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cid\/ciu862","volume":"60","author":"RK Heaton","year":"2015","unstructured":"Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60(3):473\u201380.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1857_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1017\/S1355617704102130","volume":"10","author":"RK Heaton","year":"2004","unstructured":"Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317\u201331.","journal-title":"J Int Neuropsychol Soc"},{"issue":"Suppl 1","key":"1857_CR10","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1097\/00002030-200418001-00004","volume":"18","author":"CH Hinkin","year":"2004","unstructured":"Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (London, England). 2004;18(Suppl 1):S19\u201325.","journal-title":"AIDS (London, England)"},{"issue":"7","key":"1857_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","volume":"40","author":"MF Folstein","year":"1983","unstructured":"Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Arch Gen Psychiatry. 1983;40(7):812.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1857_CR12","doi-asserted-by":"publisher","first-page":"e32898","DOI":"10.1371\/journal.pone.0032898","volume":"7","author":"J Kwasa","year":"2012","unstructured":"Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer A-CL. Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One. 2012;7(3):e32898.","journal-title":"PLoS One"},{"issue":"17","key":"1857_CR13","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1097\/QAD.0000000000001968","volume":"32","author":"B Milanini","year":"2018","unstructured":"Milanini B, Paul R, Bahemana E, Adamu Y, Kiweewa F, Langat R, Owuoth J, Allen E, Polyak C, Ake J, et al. Limitations of the International HIV Dementia Scale in the current era. AIDS (London, England). 2018;32(17):2477\u201383.","journal-title":"AIDS (London, England)"},{"issue":"13","key":"1857_CR14","first-page":"1367","volume":"19","author":"NC Sacktor","year":"2005","unstructured":"Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (London, England). 2005;19(13):1367\u201374.","journal-title":"AIDS (London, England)"},{"key":"1857_CR15","doi-asserted-by":"publisher","unstructured":"Masika GM, Yu DSF, Li PWC. Accuracy of the Montreal Cognitive Assessment in Detecting Mild Cognitive Impairment and Dementia in the Rural African Population. Arch Clin Neuropsychol. 2020. https:\/\/doi.org\/10.1093\/arclin\/acz086.","DOI":"10.1093\/arclin\/acz086"},{"issue":"5","key":"1857_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s11481-013-9505-1","volume":"8","author":"S Cross","year":"2013","unstructured":"Cross S, Onen N, Gase A, Overton ET, Ances BM. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J NeuroImmune Pharmacol. 2013;8(5):1114\u201322.","journal-title":"J NeuroImmune Pharmacol"},{"issue":"9","key":"1857_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40265-013-0059-6","volume":"73","author":"L Nabha","year":"2013","unstructured":"Nabha L, Duong L, Timpone J. HIV-associated neurocognitive disorders: perspective on management strategies. Drugs. 2013;73(9):893\u2013905.","journal-title":"Drugs"},{"issue":"2","key":"1857_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","volume":"19","author":"SP Woods","year":"2009","unstructured":"Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19(2):152\u201368.","journal-title":"Neuropsychol Rev"},{"key":"1857_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.12688\/aasopenres.12921.2","volume":"1","author":"PN Mwangala","year":"2019","unstructured":"Mwangala PN, Newton CR, Abas M, Abubakar A. Screening tools for HIV-associated neurocognitive disorders among adults living with HIV in sub-Saharan Africa: a scoping review. AAS Open Res. 2019;1:28.","journal-title":"AAS Open Res"},{"issue":"5","key":"1857_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10865-009-9212-9","volume":"32","author":"TI Lovejoy","year":"2009","unstructured":"Lovejoy TI, Suhr JA. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med. 2009;32(5):389\u2013405.","journal-title":"J Behav Med"},{"key":"1857_CR21","doi-asserted-by":"publisher","first-page":"641913","DOI":"10.1155\/2015\/641913","volume":"2015","author":"EM Tedaldi","year":"2015","unstructured":"Tedaldi EM, Minniti NL, Fischer T. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int. 2015;2015:641913.","journal-title":"Biomed Res Int"},{"issue":"10","key":"1857_CR22","doi-asserted-by":"publisher","first-page":"e820","DOI":"10.1016\/j.ijid.2013.06.011","volume":"17","author":"AG Habib","year":"2013","unstructured":"Habib AG, Yakasai AM, Owolabi LF, Ibrahim A, Habib ZG, Gudaji M, Karaye KM, Ibrahim DA, Nashabaru I. Neurocognitive impairment in HIV-1-infected adults in sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis. 2013;17(10):e820\u201331.","journal-title":"Int J Infect Dis"},{"issue":"Suppl 1","key":"1857_CR23","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1097\/QAI.0000000000000258","volume":"67","author":"D Chibanda","year":"2014","unstructured":"Chibanda D, Benjamin L, Weiss HA, Abas M. Mental, neurological, and substance use disorders in people living with HIV\/AIDS in low- and middle-income countries. J Acquir Immune Defic Syndr (1999). 2014;67(Suppl 1):S54\u201367.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"1","key":"1857_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13803395.2012.733682","volume":"35","author":"J Heaps","year":"2013","unstructured":"Heaps J, Valcour V, Chalermchai T, Paul R, Rattanamanee S, Siangphoe U, Sithinamsuwan P, Chairangsaris P, Nidhinandana S, Tipsuk S, et al. Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. J Clin Exp Neuropsychol. 2013;35(1):1\u20138.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"1857_CR25","first-page":"120","volume":"18","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Qiao L, Ding W, Wei F, Zhao Q, Wang X, Shi Y, Li N, Smith D, Chen D. An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China. J Neuro-Oncol. 2012;18(2):120\u20136.","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"1857_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/NMD.0b013e31824cc225","volume":"200","author":"KA Hestad","year":"2012","unstructured":"Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR Jr, Imasiku ML, Kalima K, Heaton RK. Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J Nerv Ment Dis. 2012;200(4):336\u201342.","journal-title":"J Nerv Ment Dis"},{"issue":"2","key":"1857_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147182","volume":"11","author":"W Royal 3rd","year":"2016","unstructured":"Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, et al. Associations between cognition, gender and monocyte activation among HIV infected individuals in Nigeria. PLoS One. 2016;11(2):e0147182.","journal-title":"PLoS One"},{"key":"1857_CR28","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2147\/NDT.S105481","volume":"12","author":"N Kabuba","year":"2016","unstructured":"Kabuba N, Menon JA, Franklin DR Jr, Heaton RK, Hestad KA. HIV- and AIDS-associated neurocognitive functioning in Zambia - a perspective based on differences between the genders. Neuropsychiatr Dis Treat. 2016;12:2021\u20138.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1857_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2377-13-86","volume":"13","author":"J Atashili","year":"2013","unstructured":"Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O'Donnell JK, Ndumbe PM, Njamnshi AK. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol. 2013;13:86.","journal-title":"BMC Neurol"},{"issue":"2","key":"1857_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2989\/16085906.2011.593373","volume":"10","author":"E Breuer","year":"2011","unstructured":"Breuer E, Myer L, Struthers H, Joska JA. HIV\/AIDS and mental health research in sub-Saharan Africa: a systematic review. Afr J AIDS Res. 2011;10(2):101\u201322.","journal-title":"Afr J AIDS Res"},{"issue":"2","key":"1857_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10461-009-9538-x","volume":"14","author":"JA Joska","year":"2010","unstructured":"Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S. Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav. 2010;14(2):371\u20138.","journal-title":"AIDS Behav"},{"issue":"2","key":"1857_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1017\/S0317167100005977","volume":"34","author":"FE Odiase","year":"2007","unstructured":"Odiase FE, Ogunrin OA, Ogunniyi AA. Memory performance in HIV\/AIDS--a prospective case control study. Can J Neurol Sci. 2007;34(2):154\u20139.","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"1857_CR33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1212\/01.wnl.0000252811.48891.6d","volume":"68","author":"MH Wong","year":"2007","unstructured":"Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007;68(5):350\u20135.","journal-title":"Neurology"},{"issue":"3","key":"1857_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S1355617700000230","volume":"1","author":"RK Heaton","year":"1995","unstructured":"Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, et al. The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. J Int Neuropsychol Soc. 1995;1(3):231\u201351.","journal-title":"J Int Neuropsychol Soc"},{"issue":"2","key":"1857_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/QAI.0b013e318042e1ee","volume":"45","author":"V Tozzi","year":"2007","unstructured":"Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr (1999). 2007;45(2):174\u201382.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"Suppl 1","key":"1857_CR36","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/00002030-200418001-00011","volume":"18","author":"BJ Brew","year":"2004","unstructured":"Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS (London, England). 2004;18(Suppl 1):S75\u20138.","journal-title":"AIDS (London, England)"},{"issue":"2","key":"1857_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11481-008-9143-1","volume":"4","author":"BJ Brew","year":"2009","unstructured":"Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. Neurodegeneration and ageing in the HAART era. J NeuroImmune Pharmacol. 2009;4(2):163\u201374.","journal-title":"J NeuroImmune Pharmacol"},{"issue":"5","key":"1857_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","volume":"73","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, Woods SP, McCutchan JA, Heaton RK, Ellis RJ. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology. 2009;73(5):342\u20138.","journal-title":"Neurology"},{"issue":"11","key":"1857_CR39","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","volume":"23","author":"CM Marra","year":"2009","unstructured":"Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS (London, England). 2009;23(11):1359\u201366.","journal-title":"AIDS (London, England)"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01857-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01857-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01857-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:28:15Z","timestamp":1626218895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01857-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01857-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"8 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Moi University School of Medicine and Moi Teaching and Referral Hospital Institutional Research and Ethics Committee approved this study. Written informed consent was obtained from all the study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}